Emory University: Brain Neoplasms trials

The registry lists 17 Brain Neoplasms studies with Emory University as lead sponsor. 4 are open to participants now and 2 have results posted.

Early Phase 1 2Phase 1 7Phase 2 4No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor SurvivorsRecruitingNCT06799481Not applicable
• Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain MetastasesRecruitingNCT06328686Early Phase 1
• Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS TrialRecruitingNCT06132685Phase 2
• Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI StudyRecruitingNCT04278118Not applicable
• Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain MetastasesCompletedNCT02858869Phase 1Results posted
• Hypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain MetastasisCompletedNCT01705548Not applicableResults posted
• Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain MetastasesTerminatedNCT05341349Phase 1
• Radiosurgery Before Surgery for the Treatment of Brain MetastasesCompletedNCT04895592Early Phase 1
• Stereotactic Radiosurgery With Abemaciclib, Ribociclib, or Palbociclib in Treating Patients With Hormone Receptor Positive Breast Cancer With Brain MetastasesWithdrawnNCT04585724Phase 1
• WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain TumorsCompletedNCT04334863Phase 1
• Utility of Perfusion MRI to Detect Radiation Necrosis in Patients With Brain MetastasesCompletedNCT03680144Not applicable
• Abemaciclib in Children With DIPG or Recurrent/Refractory Solid TumorsCompletedNCT02644460Phase 1
• Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS TumorsActive, not recruitingNCT02574728Phase 2
• Phase I Trial of Stereotactic Radiosurgery Following Surgical Resection of Brain MetastasesCompletedNCT01395407Phase 1
• Assessment of Systemically Administered Torisel Delivery to Brain Tumors by Intratumoral MicrodialysisWithdrawnNCT00949026Phase 1
• Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain NeoplasmsCompletedNCT00004688Phase 2
• Suramin in Treating Patients With Recurrent Primary Brain TumorsCompletedNCT00002639Phase 2